B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TRPV5

MOLECULAR TARGET

transient receptor potential cation channel subfamily V member 5

UniProt: Q9NQA5NCBI Gene: 563023 compounds

TRPV5 (transient receptor potential cation channel subfamily V member 5) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TRPV5

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1tetrahydrocannabivarin2.208
2Econazole0.691
3Miconazole0.691

About TRPV5 as a Drug Target

TRPV5 (transient receptor potential cation channel subfamily V member 5) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented TRPV5 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TRPV5 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.